Search PubMed⌕ Search

Biomedical subjects

J Harris

Publications and source records attributed to J Harris.

At least 415 records · Page 23Linked to original sources
PubMed1981

A new capillary tube agglutination-inhibition test for the detection of circulating immune complexes containing endogenously bound C1q.

The C1q agglutination-inhibition test (C1q-AIT) is a sensitive assay, capable of detecting circulating immune complexes (CIC) containing as little as 40 ng C1q. This non-isotopic test can be easily performed in 4 h from the receipt of the serum sample (including the isolation of CIC by PEG 6000 percipitation). The reagents are stable for at least 6 months under normal refrigeration. Because a carefully standardized C1q- anti-C1q reaction is used, CIC can be semi-quantitated by a routine titration procedure. Sera from patients with diseases reported to be associated with CIC gave significantly high test results, while diseases not normally associated with CIC (e.g. OA, gout, allergy) gave low frequencies of positive results. The C1q-AIT for CIC containing endogenously bound C1q was shown to be equivalent to and more sensitive than the [125I]C1q-BA for CIC containing exogenously bound C1q.

Antigen-Antibody Complex↗
PubMed1981

Tests of hallucinations of "Ruth'.

Some tests are reported on a young woman who was believed to have unusual powers of eidetic imagery and voluntary control of vivid hallucinations. No evidence was found of abnormal eidetic ability. Measurements of detection thresholds for light of different wavelengths, while the subject tried to hallucinate various colours, suggested that the supposed hallucinations acted like coloured filters held over the eye.

Afterimage↗
PubMed1981

Ethical problems in the management of some severely handicapped children.

This paper examines some of the arguments advanced and acted upon by doctors concerned in decisions about whether severely handicapped patients should live or die. It criticises the view that 'selective treatment' is morally preferable to infanticide and shows how the standard arguments advanced for this preference fail to sustain it. It argues that the self-deception, which is sometimes cited as a sign of humanity in these cases, and which is implicit in the term 'selective treatment' is more dangerous than is the remote chance of brutalisation which is often cited as the danger of active euthanasia.

Child↗
PubMed1981

A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.

Spleen cells from BALB/c mice immunized with MOPC 315 IgA were fused with P3X63/Ag8 myeloma cells. Hybrid clones were screened for antibody production by a plate-binding radioimmunoassay in which MOPC 315 IgA was reacted with culture supernatants and 125I-protein A. One antibody-producing hybridoma clone (D10) was selected and injected i.p. into BALB/c mice. Ascitic fluid of tum or-bearing animals reacted specifically with MOPC 315 IgA and the reaction was inhibited by DNP- aminocaproic acid, indicating that the monoclonal antibody was directed against the hapten-binding site of MOPC 315 IgA. The monoclonal antiidiotypic antibody was of the complement (C)-binding IgG2a subclass and inhibited IgA production and growth of MOPC 315 cells in vitro in the presence of guinea pig C, as assessed by inhibition of formation of plaques and colonies by MOPC 315 cells in agar.

Animals↗
PubMed1980

Long-term results of saphenous vein graft arteriovenous fistulas.

The long-term results of autogenous saphenous vein grafts for vascular access were examined in 70 patients. The cumulative patency rate was 66 percent at 2 years and 40 percent at 3 years. No difference could be detected in the occlusion rate of grafts in patients who received a kidney transplant and those who did not. Intraoperative measurement of blood flow through the grafts did not prove useful as an indicator of long-term patency. No deaths were attributable to the grafts, and major complications were limited to infection in three patients and distal ischemia in two; these complications necessitated ligation of the graft in all five patients.

Adult↗
PubMed1980

Hypochloremic alkalosis in infants associated with soy protein formula.

Thirteen infants, 2 to 10 months of age, developed hypochloremic alkalosis (serum chloride 59 to 92 mEq/l) while taking Neo-Mull-Soy (Syntex), a soy-based formula low in chloride (measured to be 0 to 2 mEq/l) but with considerable potassium citrate. Range of symptoms included lethargy, anorexia, mild spitting up, diarrhea, hematuria, and growth failure. Urine chloride excretion was less than 3 mEq/l. Plasma renin activity or aldosterone, measured in six infants, was elevated. All responded promptly to supplemental salt. One infant receiving Neo-Mull-Soy redeveloped alkalosis when supplemental salt was discontinued. Two of nine apparently normal infants receiving Neo-Mull-Soy also had hypochloremia (85, 86 mEq/l). Three of four receiving Prosobee (Mead Johnson; Cl content 7 mEq/l) had urine chloride concentration less than 20 mEq/l. The chloride content of some infant formulas is insufficient to offset salt losses following mild stress.

Alkalosis↗